1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid,
JNJ 42041935,
JNJ-42041935,
JNJ42041935,
JNJ-42041935,
1193383-09-3,
UNII-T4PPL01131,
CHEMBL3115312,
T4PPL01131,
1H-Pyrazole-4-carboxylic acid, 1-(6-chloro-5-(trifluoromethoxy)-1H-benzimidazol-2-yl)-,
1-(5-CHLORO-6-(TRIFLUOROMETHOXY)-1H-BENZO[D]IMIDAZOL-2-YL)-1H-PYRAZOLE-4-CARBOXYLIC ACID,
1H-Pyrazole-4-carboxylic acid, 1-[6-chloro-5-(trifluoromethoxy)-1H-benzimidazol-2-yl]-,
JNJ 42041935,
HIF-PHD Inhibitor II,
SCHEMBL1192988,
EX-A740,
BCP16311,
BDBM50446900,
MFCD25541711,
ZINC68199903,
AKOS030260391,
AKOS030526304,
CS-4216,
NCGC00484069-01,
AK547071,
HY-12832,
J-690055,
1-[6-chloro-5-(trifluoromethoxy)-1H-1,3-benzodiazol-2-yl]-1H-pyrazole-4-carboxylic acid,
D08JSE,
HIF-PH inhibitors (anemia),
FXHHASJVTYRJHH-UHFFFAOYSA-N,
JNJ42041935,
A15793,
HIF-PH inhibitors (anemia), Johnson & Johnson,
C559853,
1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid,
Hypoxia inducible factor prolyl hydroxylase inhibitors (anemia), Johnson & Johnson,
N2-1H-Benzimidazol-6-yl-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine,
JNJ-420419351-(6-chloro-5-trifluoromethoxy-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid,